Medications for Anaplastic Thyroid Cancer
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Anaplastic Thyroid Cancer.
Found 2 Approved Drugs for Anaplastic Thyroid Cancer
Tafinlar
Generic Name
Dabrafenib
Tafinlar
Generic Name
Dabrafenib
Form: Tablet, Capsule
Method of administration: Oral
FDA approval date: April 01, 2016
Classification: Kinase Inhibitor
TAFINLAR is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test.
Mekinist
Generic Name
Trametinib
Mekinist
Generic Name
Trametinib
Form: Tablet, Powder
Method of administration: Oral
FDA approval date: March 17, 2016
Classification: Kinase Inhibitor
MEKINIST is a kinase inhibitor indicated as a single agent for the treatment of BRAF-inhibitor treatment-naïve patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA-approved test.
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances